Syros Pharmaceuticals, Inc. Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Syros Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Syros Pharmaceuticals, Inc. for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Quirk Gerald E | Chief Legal Officer | Option Exercise | A | 13.30 | 11,666 | 155,158 | 11,666 | |
| Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Quirk Gerald E | Chief Legal Officer | Option Exercise | A | 10.09 | 75,000 | 756,750 | 75,000 | |
| Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Roth David | Chief Medical Offic ... | Option Exercise | A | 10.09 | 75,000 | 756,750 | 75,000 | |
| Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | A | 10.09 | 75,000 | 756,750 | 75,000 | |
| Feb 21 2018 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 10.09 | 285,000 | 2,875,650 | 285,000 | |
| Feb 02 2018 | SYRS | Syros Pharmaceutic ... | AKKARAJU SRINIVAS | Director | Buy | P | 9.55 | 209,424 | 1,999,999 | 1,059,938 | 850.5 K to 1.1 M (+24.62 %) |